Business Standard

Tuesday, January 07, 2025 | 08:20 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Clot mystery thickens: Opinion divided over AstraZeneca vaccine roll-out

Thailand, Bulgaria delay jab launch; WHO, France, Germany support shot

Photo: Reuters
Premium

Astrazeneca clarified that there was no evidence “of an increased risk of pulmonary embolism or deep vein thrombosis.” | Photo: Reuters

Agencies
Problems with AstraZeneca’s Covid-19 vaccine have deepened, with at least 10 countries suspending use of the shot over safety concerns that the World Health Organization, Canada, Germany, and France — along with many other nations —say are unfounded. The company, too, clarified that there was no evidence “of an increased risk of pulmonary embolism or deep vein thrombosis.”

Austria was the first to raise concerns last weekend when it stopped using some supplies of AstraZeneca’s vaccine as a precaution following reports of a death and illness among recipients.

In rapid succession, Denmark, Italy and Norway echoed the move, pointing to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in